EP3401327
MISMUNARGREINANDI, TJÁÐAR AFURÐIR ERFÐAVÍSA Í ÆXLUM OG NOTKUN ÞEIRRA
Status:
EP Einkaleyfi útrunniðEP appl. date:
18.5.2005EP published:
13.1.2021EP application number:
18167570.3
EP translation filed:
24.3.2021Grant published:
15.4.2021EPO information:
European Patent Register
Max expiry date:
17.5.2025Expiry date:
17.5.2025
Title:
GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THEIR USES
Timeline
Today
18.5.2005EP application
13.1.2021EP Publication
24.3.2021Translation submitted
15.4.2021Registration published
17.5.2025Expires
Owner
Name:
Astellas Pharma Inc.Address:
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP
Inventor
Name:
TÜRECI, ÖzlemAddress:
55116 Mainz, DE
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
KOSLOWSKI, MichaelAddress:
65933 Frankfurt, DE
Name:
FRITZ, StefanAddress:
55237 Flonheim, DE
Name:
GEPPERT, Harald-GerhardAddress:
42697 Solingen, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
102004024617Date:
18.5.2004Country:
DE
Classification
Categories:
C07K 14/47, C07K 16/30, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 17
Paid: 17.5.2021
Expires: 17.5.2022
Payer: Patice ehf.
Number: 18
Paid: 3.5.2022
Expires: 17.5.2023
Payer: Patice ehf.
Number: 19
Paid: 23.5.2023
Expires: 17.5.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 2.5.2024
Expires: 17.5.2025
Payer: Árnason Faktor ehf.